VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q60059180  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000332.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q60059180‏
024 ‎‡a  0000-0002-3736-3660‏ ‎‡2  orcid‏
024 ‎‡a  35421761700‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q60059180‏
043 ‎‡c  US‏
100 0 ‎‡a  A. Dusty Miller‏ ‎‡c  researcher ORCID ID = 0000-0002-3736-3660‏ ‎‡9  en‏
400 0 ‎‡a  A. Dusty Miller‏ ‎‡c  Amerikaans onderzoeker‏ ‎‡9  nl‏
670 ‎‡a  Author's A CMV-actin-globin hybrid promoter improves adeno-associated viral vector gene expression in the arterial wallin vivo‏
670 ‎‡a  Author's AAV-mediated gene transfer to mouse lungs‏
670 ‎‡a  Author's Ability of hyaluronidase 2 to degrade extracellular hyaluronan is not required for its function as a receptor for jaagsiekte sheep retrovirus‏
670 ‎‡a  Author's Acutely transforming retrovirus expressing Nras generated from HT-1080 fibrosarcoma cells infected with the human retrovirus XMRV.‏
670 ‎‡a  Author's Adeno-associated virus types 5 and 6 use distinct receptors for cell entry‏
670 ‎‡a  Author's Adeno-associated virus vectors preferentially transduce cells in S phase.‏
670 ‎‡a  Author's Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells.‏
670 ‎‡a  Author's Amino acid residues that are important for Hyal2 function as a receptor for jaagsiekte sheep retrovirus‏
670 ‎‡a  Author's An all-feline retroviral packaging system for transduction of human cells‏
670 ‎‡a  Author's Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, and fibroblasts. A new method for diagnosing Duchenne's muscular dystrophy.‏
670 ‎‡a  Author's APOBEC3-mediated hypermutation of retroviral vectors produced from some retrovirus packaging cell lines‏
670 ‎‡a  Author's Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation‏
670 ‎‡a  Author's Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production.‏
670 ‎‡a  Author's Chapter 7 Flow Cytometric Techniques for Measurement of Cytochrome P-450 Activity in Viable Cells‏
670 ‎‡a  Author's Correction for Vigdorovich et al., Expression and Characterization of a Soluble, Active Form of the Jaagsiekte Sheep Retrovirus Receptor, Hyal2‏
670 ‎‡a  Author's Development and Applications of Retroviral Vectors‏
670 ‎‡a  Author's Disruption of thiamine uptake and growth of cells by feline leukemia virus subgroup A.‏
670 ‎‡a  Author's DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors.‏
670 ‎‡a  Author's Downregulation of cell surface CD4 by nef‏
670 ‎‡a  Author's Efficient metabolism of benzo‏
670 ‎‡a  Author's Efficient metabolism of benzo(a)pyrene at nanomolar concentrations by intact murine hepatoma cells‏
670 ‎‡a  Author's Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene.‏
670 ‎‡a  Author's Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptor‏
670 ‎‡a  Author's Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.‏
670 ‎‡a  Author's Enhancement of enveloped virus entry by phosphatidylserine.‏
670 ‎‡a  Author's Envelope fusion protein binding studies in an inducible model of retrovirus receptor expression and in CD34(+) cells emphasize limited transduction at low receptor levels.‏
670 ‎‡a  Author's Envelope-induced cell transformation by ovine betaretroviruses‏
670 ‎‡a  Author's Envelope proteins of Jaagsiekte sheep retrovirus and enzootic nasal tumor virus induce similar bronchioalveolar tumors in lungs of mice‏
670 ‎‡a  Author's Erratum to “Efficient Transduction of Skeletal Muscle Using Vectors Based on Adeno-associated Virus Serotype 6”.‏
670 ‎‡a  Author's Ethylated fluoresceins: Assay of cytochrome P-450 activity and application to measurements in single cells by flow cytometry‏
670 ‎‡a  Author's Evidence against a role for jaagsiekte sheep retrovirus in human lung cancer.‏
670 ‎‡a  Author's Expression and characterization of a soluble, active form of the jaagsiekte sheep retrovirus receptor, Hyal2.‏
670 ‎‡a  Author's Expression of a human beta globin gene transduced by a retroviral vector in murine erythroleukemia cells‏
670 ‎‡a  Author's Expression of human alpha1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs.‏
670 ‎‡a  Author's Expression of the human beta-globin gene after retroviral transfer into murine erythroleukemia cells and human BFU-E cells.‏
670 ‎‡a  Author's Factors involved in production of helper virus-free retrovirus vectors.‏
670 ‎‡a  Author's Gene Therapy for Immunodeficiency and Cancer‏
670 ‎‡a  Author's Gene transfer as an approach to cure patients with hemophilia A or B.‏
670 ‎‡a  Author's Generation of Stable Vector-Producing Cells for Retroviral Vectors‏
670 ‎‡a  Author's Heterogeneity in the Rate of Benzo[a]pyrene Metabolism in Single Cells: Quantitation Using Flow Cytometry‏
670 ‎‡a  Author's High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung‏
670 ‎‡a  Author's Human gene therapy comes of age.‏
670 ‎‡a  Author's Human RON receptor tyrosine kinase induces complete epithelial-to-mesenchymal transition but causes cellular senescence.‏
670 ‎‡a  Author's Hyaluronidase 2 and its intriguing role as a cell-entry receptor for oncogenic sheep retroviruses.‏
670 ‎‡a  Author's Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus‏
670 ‎‡a  Author's Identification of Hyal2 as the cell-surface receptor for jaagsiekte sheep retrovirus and ovine nasal adenocarcinoma virus.‏
670 ‎‡a  Author's Identification of the myelin protein plasmolipin as the cell entry receptor for Mus caroli endogenous retrovirus.‏
670 ‎‡a  Author's Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6.‏
670 ‎‡a  Author's Improved enzootic nasal tumor virus pseudotype packaging cell lines reveal virus entry requirements in addition to the primary receptor Hyal2.‏
670 ‎‡a  Author's Improved transfer of the leukocyte integrin CD18 subunit into hematopoietic cell lines by using retroviral vectors having a gibbon ape leukemia virus envelope.‏
670 ‎‡a  Author's Insulin-gene regulation‏
670 ‎‡a  Author's Jaagsiekte sheep retrovirus and enzootic nasal tumor virus promoters drive gene expression in all airway epithelial cells of mice but only induce tumors in the alveolar region of the lungs‏
670 ‎‡a  Author's Jaagsiekte sheep retrovirus Env protein stabilizes retrovirus vectors against inactivation by lung surfactant, centrifugation, and freeze-thaw cycling.‏
670 ‎‡a  Author's Jaagsiekte sheep retrovirus envelope efficiently pseudotypes human immunodeficiency virus type 1-based lentiviral vectors‏
670 ‎‡a  Author's Keratinocyte Growth Factor Stimulates Transduction of the Respiratory Epithelium by Retroviral Vectors‏
670 ‎‡a  Author's Letter to the Editor: Hyal2, where are you?‏
670 ‎‡a  Author's Long-term expression of the human beta-globin gene after retroviral transfer into pluripotent hematopoietic stem cells of the mouse‏
670 ‎‡a  Author's Long-Term Persistence of Canine Hematopoietic Cells Genetically Marked by Retrovirus Vectors‏
670 ‎‡a  Author's Lung cancer in mice induced by the jaagsiekte sheep retrovirus envelope protein is not maintained by rare cancer stem cells, but tumorigenicity does correlate with Wnt pathway activation.‏
670 ‎‡a  Author's Lung cancer induced in mice by the envelope protein of jaagsiekte sheep retrovirus (JSRV) closely resembles lung cancer in sheep infected with JSRV‏
670 ‎‡a  Author's Lung tumor development and spontaneous regression in lambs coinfected with Jaagsiekte sheep retrovirus and ovine lentivirus.‏
670 ‎‡a  Author's Many nonmammalian cells exhibit postentry blocks to transduction by gammaretroviruses pseudotyped with various viral envelopes, including vesicular stomatitis virus G glycoprotein.‏
670 ‎‡a  Author's Mechanism for XMRV neurotoxicity.‏
670 ‎‡a  Author's Mechanism of cell entry and transformation by enzootic nasal tumor virus.‏
670 ‎‡a  Author's Multiple integrated copies and high-level production of the human retrovirus XMRV‏
670 ‎‡a  Author's Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells‏
670 ‎‡a  Author's No biological evidence of XMRV in blood or prostatic fluid from prostate cancer patients‏
670 ‎‡a  Author's Oncogenic transformation by the jaagsiekte sheep retrovirus envelope protein.‏
670 ‎‡a  Author's PA 317 retrovirus packaging cells‏
670 ‎‡a  Author's Persistent, therapeutically relevant levels of human granulocyte colony-stimulating factor in mice after systemic delivery of adeno-associated virus vectors.‏
670 ‎‡a  Author's Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus.‏
670 ‎‡a  Author's Phosphatidylserine treatment relieves the block to retrovirus infection of cells expressing glycosylated virus receptors.‏
670 ‎‡a  Author's Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors‏
670 ‎‡a  Author's Putative phosphatidylinositol 3-kinase (PI3K) binding motifs in ovine betaretrovirus Env proteins are not essential for rodent fibroblast transformation and PI3K/Akt activation‏
670 ‎‡a  Author's Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.‏
670 ‎‡a  Author's Regulated expression of the human beta-globin gene after retroviral transfer into murine and human hematopoietic cells.‏
670 ‎‡a  Author's Regulation of human gene therapy.‏
670 ‎‡a  Author's Replication of Mus dunni endogenous retrovirus depends on promoter activation followed by enhancer multimerization.‏
670 ‎‡a  Author's Retroviral vector production.‏
670 ‎‡a  Author's Retroviral Vector Production by Transient Transfection‏
670 ‎‡a  Author's Retroviral Vectors for Gene Transfer‏
670 ‎‡a  Author's Retroviral vectors: from cancer viruses to therapeutic tools‏
670 ‎‡a  Author's Retroviral Vectors in Gene Therapy‏
670 ‎‡a  Author's Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells‏
670 ‎‡a  Author's Retrovirus-Mediated Transfer of the cDNA for Human Glucocerebrosidase into Peripheral Blood Repopulating Cells of Patients with Gaucher's Disease. University of Wisconsin, Madison, Wisconsin‏
670 ‎‡a  Author's Retrovirus packaging cells.‏
670 ‎‡a  Author's Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry‏
670 ‎‡a  Author's Role of virus receptor Hyal2 in oncogenic transformation of rodent fibroblasts by sheep betaretrovirus env proteins‏
670 ‎‡a  Author's Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production.‏
670 ‎‡a  Author's Serine phosphorylation-independent downregulation of cell-surface CD4 by nef‏
670 ‎‡a  Author's Sheep retrovirus structural protein induces lung tumours‏
670 ‎‡a  Author's Single-strand nicks induce homologous recombination with less toxicity than double-strand breaks using an AAV vector template‏
670 ‎‡a  Author's Study on Contribution of Genetically Marked Peripheral Blood Repopulating Cells to Hematopoietic Reconstitution After Transplantation. Fred Hutchinson Cancer Research Center, Seattle, Washington‏
670 ‎‡a  Author's Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure‏
670 ‎‡a  Author's Successful regional delivery and long-term expression of a dystrophin gene in canine muscular dystrophy: a preclinical model for human therapies‏
670 ‎‡a  Author's Superior transduction of mouse hematopoietic stem cells with 10A1 and VSV-G pseudotyped retrovirus vectors.‏
670 ‎‡a  Author's Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.‏
670 ‎‡a  Author's Systemic Production of Human Granulocyte Colony-Stimulating Factor in Nonhuman Primates by Transplantation of Genetically Modified Myoblasts‏
670 ‎‡a  Author's T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.‏
670 ‎‡a  Author's The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines.‏
670 ‎‡a  Author's The left half of the XMRV retrovirus is present in an endogenous retrovirus of NIH/3T3 Swiss mouse cells‏
670 ‎‡a  Author's The prostate cancer-associated human retrovirus XMRV lacks direct transforming activity but can induce low rates of transformation in cultured cells‏
670 ‎‡a  Author's The RD114/simian type D retrovirus receptor is a neutral amino acid transporter‏
670 ‎‡a  Author's Transduction of Cell Lines by Retroviral Vectors‏
670 ‎‡a  Author's Transduction of Primary Hematopoietic Cells by Retroviral Vectors‏
670 ‎‡a  Author's Transformation and scattering activities of the receptor tyrosine kinase RON/Stk in rodent fibroblasts and lack of regulation by the jaagsiekte sheep retrovirus receptor, Hyal2‏
670 ‎‡a  Author's Transformation of madin-darby canine kidney epithelial cells by sheep retrovirus envelope proteins.‏
670 ‎‡a  Author's Use of different but overlapping determinants in a retrovirus receptor accounts for non-reciprocal interference between xenotropic and polytropic murine leukemia viruses.‏
670 ‎‡a  Author's Use of Retroviral Vectors for Gene Transfer and Expression‏
670 ‎‡a  Author's Viral and cellular fos proteins: A comparative analysis‏
670 ‎‡a  Author's Xpr1 is an atypical G-protein-coupled receptor that mediates xenotropic and polytropic murine retrovirus neurotoxicity‏
909 ‎‡a  (scopus) 35421761700‏ ‎‡9  1‏
909 ‎‡a  (orcid) 0000000237363660‏ ‎‡9  1‏
919 ‎‡a  905actinglobinhybridpromoterimprovesadenoassociatedviralvectorgeneexpressioninthearterialwallinvivo‏ ‎‡A  A CMV-actin-globin hybrid promoter improves adeno-associated viral vector gene expression in the arterial wallin vivo‏ ‎‡9  1‏
919 ‎‡a  aavmediatedgenetransfertomouselungs‏ ‎‡A  AAV-mediated gene transfer to mouse lungs‏ ‎‡9  1‏
919 ‎‡a  abilityofhyaluronidase2todegradeextracellularhyaluronanisnotrequiredforitsfunctionasareceptorforjaagsiektesheepretrovirus‏ ‎‡A  Ability of hyaluronidase 2 to degrade extracellular hyaluronan is not required for its function as a receptor for jaagsiekte sheep retrovirus‏ ‎‡9  1‏
919 ‎‡a  acutelytransformingretrovirusexpressingnrasgeneratedfromht1080fibrosarcomacellsinfectedwiththehumanretrovirusxmrv‏ ‎‡A  Acutely transforming retrovirus expressing Nras generated from HT-1080 fibrosarcoma cells infected with the human retrovirus XMRV.‏ ‎‡9  1‏
919 ‎‡a  adenoassociatedvirustypes5and6usedistinctreceptorsforcellentry‏ ‎‡A  Adeno-associated virus types 5 and 6 use distinct receptors for cell entry‏ ‎‡9  1‏
919 ‎‡a  adenoassociatedvirusvectorspreferentiallytransducecellsinsphase‏ ‎‡A  Adeno-associated virus vectors preferentially transduce cells in S phase.‏ ‎‡9  1‏
919 ‎‡a  adenoassociatedvirusvectorstransduceprimarycellsmuchlessefficientlythanimmortalizedcells‏ ‎‡A  Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells.‏ ‎‡9  1‏
919 ‎‡a  aminoacidresiduesthatareimportantforhyal2functionasareceptorforjaagsiektesheepretrovirus‏ ‎‡A  Amino acid residues that are important for Hyal2 function as a receptor for jaagsiekte sheep retrovirus‏ ‎‡9  1‏
919 ‎‡a  allfelineretroviralpackagingsystemfortransductionofhumancells‏ ‎‡A  An all-feline retroviral packaging system for transduction of human cells‏ ‎‡9  1‏
919 ‎‡a  analysisofdystrophinexpressionafteractivationofmyogenesisinamniocyteschorionicvilluscellsandfibroblastsanewmethodfordiagnosingduchennesmusculardystrophy‏ ‎‡A  Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, and fibroblasts. A new method for diagnosing Duchenne's muscular dystrophy.‏ ‎‡9  1‏
919 ‎‡a  apobec3mediatedhypermutationofretroviralvectorsproducedfromsomeretroviruspackagingcelllines‏ ‎‡A  APOBEC3-mediated hypermutation of retroviral vectors produced from some retrovirus packaging cell lines‏ ‎‡9  1‏
919 ‎‡a  candidatetumorsuppressorhyal2isaglycosylphosphatidylinositolgpianchoredcellsurfacereceptorforjaagsiektesheepretrovirustheenvelopeproteinofwhichmediatesoncogenictransformation‏ ‎‡A  Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation‏ ‎‡9  1‏
919 ‎‡a  capsidexpressingdnainaavvectorsanditseliminationbyuseofanoversizecapsidgeneforvectorproduction‏ ‎‡A  Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production.‏ ‎‡9  1‏
919 ‎‡a  chapter7flowcytometrictechniquesformeasurementofcytochromep450activityinviablecells‏ ‎‡A  Chapter 7 Flow Cytometric Techniques for Measurement of Cytochrome P-450 Activity in Viable Cells‏ ‎‡9  1‏
919 ‎‡a  correctionforvigdorovichetalexpressionandcharacterizationofasolubleactiveformofthejaagsiektesheepretrovirusreceptorhyal2‏ ‎‡A  Correction for Vigdorovich et al., Expression and Characterization of a Soluble, Active Form of the Jaagsiekte Sheep Retrovirus Receptor, Hyal2‏ ‎‡9  1‏
919 ‎‡a  developmentandapplicationsofretroviralvectors‏ ‎‡A  Development and Applications of Retroviral Vectors‏ ‎‡9  1‏
919 ‎‡a  disruptionofthiamineuptakeandgrowthofcellsbyfelineleukemiavirussubgroupa‏ ‎‡A  Disruption of thiamine uptake and growth of cells by feline leukemia virus subgroup A.‏ ‎‡9  1‏
919 ‎‡a  dnadamagingagentsgreatlyincreasethetransductionofnondividingcellsbyadenoassociatedvirusvectors‏ ‎‡A  DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors.‏ ‎‡9  1‏
919 ‎‡a  downregulationofcellsurfacecd4bynef‏ ‎‡A  Downregulation of cell surface CD4 by nef‏ ‎‡9  1‏
919 ‎‡a  efficientmetabolismofbenzo‏ ‎‡A  Efficient metabolism of benzo‏ ‎‡9  1‏
919 ‎‡a  efficientmetabolismofbenzoapyreneatnanomolarconcentrationsbyintactmurinehepatomacells‏ ‎‡A  Efficient metabolism of benzo(a)pyrene at nanomolar concentrations by intact murine hepatoma cells‏ ‎‡9  1‏
919 ‎‡a  efficientmouseairwaytransductionfollowingrecombinationbetweenaavvectorscarryingpartsofalargergene‏ ‎‡A  Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene.‏ ‎‡9  1‏
919 ‎‡a  efficienttransductionbyanamphotropicretrovirusvectorisdependentonhighlevelexpressionofthecellsurfacevirusreceptor‏ ‎‡A  Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptor‏ ‎‡9  1‏
919 ‎‡a  efficienttransductionofskeletalmuscleusingvectorsbasedonadenoassociatedvirusserotype6‏ ‎‡A  Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.‏ ‎‡9  1‏
919 ‎‡a  enhancementofenvelopedvirusentrybyphosphatidylserine‏ ‎‡A  Enhancement of enveloped virus entry by phosphatidylserine.‏ ‎‡9  1‏
919 ‎‡a  envelopefusionproteinbindingstudiesinaninduciblemodelofretrovirusreceptorexpressionandincd34+cellsemphasizelimitedtransductionatlowreceptorlevels‏ ‎‡A  Envelope fusion protein binding studies in an inducible model of retrovirus receptor expression and in CD34(+) cells emphasize limited transduction at low receptor levels.‏ ‎‡9  1‏
919 ‎‡a  envelopeinducedcelltransformationbyovinebetaretroviruses‏ ‎‡A  Envelope-induced cell transformation by ovine betaretroviruses‏ ‎‡9  1‏
919 ‎‡a  envelopeproteinsofjaagsiektesheepretrovirusandenzooticnasaltumorvirusinducesimilarbronchioalveolartumorsinlungsofmice‏ ‎‡A  Envelope proteins of Jaagsiekte sheep retrovirus and enzootic nasal tumor virus induce similar bronchioalveolar tumors in lungs of mice‏ ‎‡9  1‏
919 ‎‡a  erratumtoefficienttransductionofskeletalmuscleusingvectorsbasedonadenoassociatedvirusserotype6‏ ‎‡A  Erratum to “Efficient Transduction of Skeletal Muscle Using Vectors Based on Adeno-associated Virus Serotype 6”.‏ ‎‡9  1‏
919 ‎‡a  ethylatedfluoresceinsassayofcytochromep450activityandapplicationtomeasurementsinsinglecellsbyflowcytometry‏ ‎‡A  Ethylated fluoresceins: Assay of cytochrome P-450 activity and application to measurements in single cells by flow cytometry‏ ‎‡9  1‏
919 ‎‡a  evidenceagainstaroleforjaagsiektesheepretrovirusinhumanlungcancer‏ ‎‡A  Evidence against a role for jaagsiekte sheep retrovirus in human lung cancer.‏ ‎‡9  1‏
919 ‎‡a  expressionandcharacterizationofasolubleactiveformofthejaagsiektesheepretrovirusreceptorhyal2‏ ‎‡A  Expression and characterization of a soluble, active form of the jaagsiekte sheep retrovirus receptor, Hyal2.‏ ‎‡9  1‏
919 ‎‡a  expressionofahumanbetaglobingenetransducedbyaretroviralvectorinmurineerythroleukemiacells‏ ‎‡A  Expression of a human beta globin gene transduced by a retroviral vector in murine erythroleukemia cells‏ ‎‡9  1‏
919 ‎‡a  expressionofhumanalpha1antitrypsininmiceanddogsfollowingaav6vectormediatedgenetransfertothelungs‏ ‎‡A  Expression of human alpha1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs.‏ ‎‡9  1‏
919 ‎‡a  expressionofthehumanbetaglobingeneafterretroviraltransferintomurineerythroleukemiacellsandhumanbfuecells‏ ‎‡A  Expression of the human beta-globin gene after retroviral transfer into murine erythroleukemia cells and human BFU-E cells.‏ ‎‡9  1‏
919 ‎‡a  factorsinvolvedinproductionofhelpervirusfreeretrovirusvectors‏ ‎‡A  Factors involved in production of helper virus-free retrovirus vectors.‏ ‎‡9  1‏
919 ‎‡a  genetherapyforimmunodeficiencyandcancer‏ ‎‡A  Gene Therapy for Immunodeficiency and Cancer‏ ‎‡9  1‏
919 ‎‡a  genetransferasanapproachtocurepatientswithhemophiliaaorb‏ ‎‡A  Gene transfer as an approach to cure patients with hemophilia A or B.‏ ‎‡9  1‏
919 ‎‡a  generationofstablevectorproducingcellsforretroviralvectors‏ ‎‡A  Generation of Stable Vector-Producing Cells for Retroviral Vectors‏ ‎‡9  1‏
919 ‎‡a  heterogeneityintherateofbenzopyrenemetabolisminsinglecellsquantitationusingflowcytometry‏ ‎‡A  Heterogeneity in the Rate of Benzo[a]pyrene Metabolism in Single Cells: Quantitation Using Flow Cytometry‏ ‎‡9  1‏
919 ‎‡a  highefficiencypromoterdependenttransductionbyadenoassociatedvirustype6vectorsinmouselung‏ ‎‡A  High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung‏ ‎‡9  1‏
919 ‎‡a  humangenetherapycomesofage‏ ‎‡A  Human gene therapy comes of age.‏ ‎‡9  1‏
919 ‎‡a  humanronreceptortyrosinekinaseinducescompleteepithelialtomesenchymaltransitionbutcausescellularsenescence‏ ‎‡A  Human RON receptor tyrosine kinase induces complete epithelial-to-mesenchymal transition but causes cellular senescence.‏ ‎‡9  1‏
919 ‎‡a  hyaluronidase2anditsintriguingroleasacellentryreceptorforoncogenicsheepretroviruses‏ ‎‡A  Hyaluronidase 2 and its intriguing role as a cell-entry receptor for oncogenic sheep retroviruses.‏ ‎‡9  1‏
919 ‎‡a  hyaluronidase2negativelyregulatesronreceptortyrosinekinaseandmediatestransformationofepithelialcellsbyjaagsiektesheepretrovirus‏ ‎‡A  Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus‏ ‎‡9  1‏
919 ‎‡a  identificationofhyal2asthecellsurfacereceptorforjaagsiektesheepretrovirusandovinenasaladenocarcinomavirus‏ ‎‡A  Identification of Hyal2 as the cell-surface receptor for jaagsiekte sheep retrovirus and ovine nasal adenocarcinoma virus.‏ ‎‡9  1‏
919 ‎‡a  identificationofthemyelinproteinplasmolipinasthecellentryreceptorformuscaroliendogenousretrovirus‏ ‎‡A  Identification of the myelin protein plasmolipin as the cell entry receptor for Mus caroli endogenous retrovirus.‏ ‎‡9  1‏
919 ‎‡a  improvedadenoassociatedvirusvectorproductionwithtransfectionofasinglehelperadenovirusgenee4orf6‏ ‎‡A  Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6.‏ ‎‡9  1‏
919 ‎‡a  improvedenzooticnasaltumorviruspseudotypepackagingcelllinesrevealvirusentryrequirementsinadditiontotheprimaryreceptorhyal2‏ ‎‡A  Improved enzootic nasal tumor virus pseudotype packaging cell lines reveal virus entry requirements in addition to the primary receptor Hyal2.‏ ‎‡9  1‏
919 ‎‡a  improvedtransferoftheleukocyteintegrincd18subunitintohematopoieticcelllinesbyusingretroviralvectorshavingagibbonapeleukemiavirusenvelope‏ ‎‡A  Improved transfer of the leukocyte integrin CD18 subunit into hematopoietic cell lines by using retroviral vectors having a gibbon ape leukemia virus envelope.‏ ‎‡9  1‏
919 ‎‡a  insulingeneregulation‏ ‎‡A  Insulin-gene regulation‏ ‎‡9  1‏
919 ‎‡a  jaagsiektesheepretrovirusandenzooticnasaltumorviruspromotersdrivegeneexpressioninallairwayepithelialcellsofmicebutonlyinducetumorsinthealveolarregionofthelungs‏ ‎‡A  Jaagsiekte sheep retrovirus and enzootic nasal tumor virus promoters drive gene expression in all airway epithelial cells of mice but only induce tumors in the alveolar region of the lungs‏ ‎‡9  1‏
919 ‎‡a  jaagsiektesheepretrovirusenvproteinstabilizesretrovirusvectorsagainstinactivationbylungsurfactantcentrifugationandfreezethawcycling‏ ‎‡A  Jaagsiekte sheep retrovirus Env protein stabilizes retrovirus vectors against inactivation by lung surfactant, centrifugation, and freeze-thaw cycling.‏ ‎‡9  1‏
919 ‎‡a  jaagsiektesheepretrovirusenvelopeefficientlypseudotypeshumanimmunodeficiencyvirustype1basedlentiviralvectors‏ ‎‡A  Jaagsiekte sheep retrovirus envelope efficiently pseudotypes human immunodeficiency virus type 1-based lentiviral vectors‏ ‎‡9  1‏
919 ‎‡a  keratinocytegrowthfactorstimulatestransductionoftherespiratoryepitheliumbyretroviralvectors‏ ‎‡A  Keratinocyte Growth Factor Stimulates Transduction of the Respiratory Epithelium by Retroviral Vectors‏ ‎‡9  1‏
919 ‎‡a  lettertotheeditorhyal2whereareyou‏ ‎‡A  Letter to the Editor: Hyal2, where are you?‏ ‎‡9  1‏
919 ‎‡a  longtermexpressionofthehumanbetaglobingeneafterretroviraltransferintopluripotenthematopoieticstemcellsofthemouse‏ ‎‡A  Long-term expression of the human beta-globin gene after retroviral transfer into pluripotent hematopoietic stem cells of the mouse‏ ‎‡9  1‏
919 ‎‡a  longtermpersistenceofcaninehematopoieticcellsgeneticallymarkedbyretrovirusvectors‏ ‎‡A  Long-Term Persistence of Canine Hematopoietic Cells Genetically Marked by Retrovirus Vectors‏ ‎‡9  1‏
919 ‎‡a  lungcancerinmiceinducedbythejaagsiektesheepretrovirusenvelopeproteinisnotmaintainedbyrarecancerstemcellsbuttumorigenicitydoescorrelatewithwntpathwayactivation‏ ‎‡A  Lung cancer in mice induced by the jaagsiekte sheep retrovirus envelope protein is not maintained by rare cancer stem cells, but tumorigenicity does correlate with Wnt pathway activation.‏ ‎‡9  1‏
919 ‎‡a  lungcancerinducedinmicebytheenvelopeproteinofjaagsiektesheepretrovirusjsrvcloselyresembleslungcancerinsheepinfectedwithjsrv‏ ‎‡A  Lung cancer induced in mice by the envelope protein of jaagsiekte sheep retrovirus (JSRV) closely resembles lung cancer in sheep infected with JSRV‏ ‎‡9  1‏
919 ‎‡a  lungtumordevelopmentandspontaneousregressioninlambscoinfectedwithjaagsiektesheepretrovirusandovinelentivirus‏ ‎‡A  Lung tumor development and spontaneous regression in lambs coinfected with Jaagsiekte sheep retrovirus and ovine lentivirus.‏ ‎‡9  1‏
919 ‎‡a  manynonmammaliancellsexhibitpostentryblockstotransductionbygammaretrovirusespseudotypedwithvariousviralenvelopesincludingvesicularstomatitisvirusgglycoprotein‏ ‎‡A  Many nonmammalian cells exhibit postentry blocks to transduction by gammaretroviruses pseudotyped with various viral envelopes, including vesicular stomatitis virus G glycoprotein.‏ ‎‡9  1‏
919 ‎‡a  mechanismforxmrvneurotoxicity‏ ‎‡A  Mechanism for XMRV neurotoxicity.‏ ‎‡9  1‏
919 ‎‡a  mechanismofcellentryandtransformationbyenzooticnasaltumorvirus‏ ‎‡A  Mechanism of cell entry and transformation by enzootic nasal tumor virus.‏ ‎‡9  1‏
919 ‎‡a  multipleintegratedcopiesandhighlevelproductionofthehumanretrovirusxmrv‏ ‎‡A  Multiple integrated copies and high-level production of the human retrovirus XMRV‏ ‎‡9  1‏
919 ‎‡a  multipleintegratedcopiesandhighlevelproductionofthehumanretrovirusxmrvxenotropicmurineleukemiavirusrelatedvirusfrom22rv1prostatecarcinomacells‏ ‎‡A  Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells‏ ‎‡9  1‏
919 ‎‡a  nobiologicalevidenceofxmrvinbloodorprostaticfluidfromprostatecancerpatients‏ ‎‡A  No biological evidence of XMRV in blood or prostatic fluid from prostate cancer patients‏ ‎‡9  1‏
919 ‎‡a  oncogenictransformationbythejaagsiektesheepretrovirusenvelopeprotein‏ ‎‡A  Oncogenic transformation by the jaagsiekte sheep retrovirus envelope protein.‏ ‎‡9  1‏
919 ‎‡a  pa317retroviruspackagingcells‏ ‎‡A  PA 317 retrovirus packaging cells‏ ‎‡9  1‏
919 ‎‡a  persistenttherapeuticallyrelevantlevelsofhumangranulocytecolonystimulatingfactorinmiceaftersystemicdeliveryofadenoassociatedvirusvectors‏ ‎‡A  Persistent, therapeutically relevant levels of human granulocyte colony-stimulating factor in mice after systemic delivery of adeno-associated virus vectors.‏ ‎‡9  1‏
919 ‎‡a  phosphatidylserineisnotthecellsurfacereceptorforvesicularstomatitisvirus‏ ‎‡A  Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus.‏ ‎‡9  1‏
919 ‎‡a  phosphatidylserinetreatmentrelievestheblocktoretrovirusinfectionofcellsexpressingglycosylatedvirusreceptors‏ ‎‡A  Phosphatidylserine treatment relieves the block to retrovirus infection of cells expressing glycosylated virus receptors.‏ ‎‡9  1‏
919 ‎‡a  prevalenceofneutralizingantibodiesagainstadenoassociatedvirusaavtypes25and6incysticfibrosisandnormalpopulationsimplicationsforgenetherapyusingaavvectors‏ ‎‡A  Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors‏ ‎‡9  1‏
919 ‎‡a  putativephosphatidylinositol3kinasepi3kbindingmotifsinovinebetaretrovirusenvproteinsarenotessentialforrodentfibroblasttransformationandpi3kaktactivation‏ ‎‡A  Putative phosphatidylinositol 3-kinase (PI3K) binding motifs in ovine betaretrovirus Env proteins are not essential for rodent fibroblast transformation and PI3K/Akt activation‏ ‎‡9  1‏
919 ‎‡a  receptorsandentrycofactorsforretrovirusesincludesingleandmultipletransmembranespanningproteinsaswellasnewlydescribedglycophosphatidylinositolanchoredandsecretedproteins‏ ‎‡A  Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.‏ ‎‡9  1‏
919 ‎‡a  regulatedexpressionofthehumanbetaglobingeneafterretroviraltransferintomurineandhumanhematopoieticcells‏ ‎‡A  Regulated expression of the human beta-globin gene after retroviral transfer into murine and human hematopoietic cells.‏ ‎‡9  1‏
919 ‎‡a  regulationofhumangenetherapy‏ ‎‡A  Regulation of human gene therapy.‏ ‎‡9  1‏
919 ‎‡a  replicationofmusdunniendogenousretrovirusdependsonpromoteractivationfollowedbyenhancermultimerization‏ ‎‡A  Replication of Mus dunni endogenous retrovirus depends on promoter activation followed by enhancer multimerization.‏ ‎‡9  1‏
919 ‎‡a  retroviralvectorproduction‏ ‎‡A  Retroviral vector production.‏ ‎‡9  1‏
919 ‎‡a  retroviralvectorproductionbytransienttransfection‏ ‎‡A  Retroviral Vector Production by Transient Transfection‏ ‎‡9  1‏
919 ‎‡a  retroviralvectorsforgenetransfer‏ ‎‡A  Retroviral Vectors for Gene Transfer‏ ‎‡9  1‏
919 ‎‡a  retroviralvectorsfromcancervirusestotherapeutictools‏ ‎‡A  Retroviral vectors: from cancer viruses to therapeutic tools‏ ‎‡9  1‏
919 ‎‡a  retroviralvectorsingenetherapy‏ ‎‡A  Retroviral Vectors in Gene Therapy‏ ‎‡9  1‏
919 ‎‡a  retrovirusmediatedgenetransductionintocanineperipheralbloodrepopulatingcells‏ ‎‡A  Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells‏ ‎‡9  1‏
919 ‎‡a  retrovirusmediatedtransferofthecdnaforhumanglucocerebrosidaseintoperipheralbloodrepopulatingcellsofpatientswithgauchersdiseaseuniversityofwisconsinmadisonwisconsin‏ ‎‡A  Retrovirus-Mediated Transfer of the cDNA for Human Glucocerebrosidase into Peripheral Blood Repopulating Cells of Patients with Gaucher's Disease. University of Wisconsin, Madison, Wisconsin‏ ‎‡9  1‏
919 ‎‡a  retroviruspackagingcells‏ ‎‡A  Retrovirus packaging cells.‏ ‎‡9  1‏
919 ‎‡a  retroviruspackagingcellsbasedon10a1murineleukemiavirusforproductionofvectorsthatusemultiplereceptorsforcellentry‏ ‎‡A  Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry‏ ‎‡9  1‏
919 ‎‡a  roleofvirusreceptorhyal2inoncogenictransformationofrodentfibroblastsbysheepbetaretrovirusenvproteins‏ ‎‡A  Role of virus receptor Hyal2 in oncogenic transformation of rodent fibroblasts by sheep betaretrovirus env proteins‏ ‎‡9  1‏
919 ‎‡a  sequencesinthecodingregionofclottingfactor8actasdominantinhibitorsofrnaaccumulationandproteinproduction‏ ‎‡A  Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production.‏ ‎‡9  1‏
919 ‎‡a  serinephosphorylationindependentdownregulationofcellsurfacecd4bynef‏ ‎‡A  Serine phosphorylation-independent downregulation of cell-surface CD4 by nef‏ ‎‡9  1‏
919 ‎‡a  sheepretrovirusstructuralproteininduceslungtumours‏ ‎‡A  Sheep retrovirus structural protein induces lung tumours‏ ‎‡9  1‏
919 ‎‡a  singlestrandnicksinducehomologousrecombinationwithlesstoxicitythandoublestrandbreaksusinganaavvectortemplate‏ ‎‡A  Single-strand nicks induce homologous recombination with less toxicity than double-strand breaks using an AAV vector template‏ ‎‡9  1‏
919 ‎‡a  studyoncontributionofgeneticallymarkedperipheralbloodrepopulatingcellstohematopoieticreconstitutionaftertransplantationfredhutchinsoncancerresearchcenterseattlewashington‏ ‎‡A  Study on Contribution of Genetically Marked Peripheral Blood Repopulating Cells to Hematopoietic Reconstitution After Transplantation. Fred Hutchinson Cancer Research Center, Seattle, Washington‏ ‎‡9  1‏
919 ‎‡a  successfulreadministrationofadenoassociatedvirusvectorstothemouselungrequirestransientimmunosuppressionduringtheinitialexposure‏ ‎‡A  Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure‏ ‎‡9  1‏
919 ‎‡a  successfulregionaldeliveryandlongtermexpressionofadystrophingeneincaninemusculardystrophyapreclinicalmodelforhumantherapies‏ ‎‡A  Successful regional delivery and long-term expression of a dystrophin gene in canine muscular dystrophy: a preclinical model for human therapies‏ ‎‡9  1‏
919 ‎‡a  superiortransductionofmousehematopoieticstemcellswith10a1andvsvgpseudotypedretrovirusvectors‏ ‎‡A  Superior transduction of mouse hematopoietic stem cells with 10A1 and VSV-G pseudotyped retrovirus vectors.‏ ‎‡9  1‏
919 ‎‡a  susceptibilityofthehumanretrovirusxmrvtoantiretroviralinhibitors‏ ‎‡A  Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.‏ ‎‡9  1‏
919 ‎‡a  systemicproductionofhumangranulocytecolonystimulatingfactorinnonhumanprimatesbytransplantationofgeneticallymodifiedmyoblasts‏ ‎‡A  Systemic Production of Human Granulocyte Colony-Stimulating Factor in Nonhuman Primates by Transplantation of Genetically Modified Myoblasts‏ ‎‡9  1‏
919 ‎‡a  tlymphocytedirectedgenetherapyforadascidinitialtrialresultsafter4years‏ ‎‡A  T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.‏ ‎‡9  1‏
919 ‎‡a  effectsofhumanserumandcerebrospinalfluidonretroviralvectorsandpackagingcelllines‏ ‎‡A  The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines.‏ ‎‡9  1‏
919 ‎‡a  lefthalfofthexmrvretrovirusispresentinanendogenousretrovirusofnih3t3swissmousecells‏ ‎‡A  The left half of the XMRV retrovirus is present in an endogenous retrovirus of NIH/3T3 Swiss mouse cells‏ ‎‡9  1‏
919 ‎‡a  prostatecancerassociatedhumanretrovirusxmrvlacksdirecttransformingactivitybutcaninducelowratesoftransformationinculturedcells‏ ‎‡A  The prostate cancer-associated human retrovirus XMRV lacks direct transforming activity but can induce low rates of transformation in cultured cells‏ ‎‡9  1‏
919 ‎‡a  rd114simiantype500retrovirusreceptorisaneutralaminoacidtransporter‏ ‎‡A  The RD114/simian type D retrovirus receptor is a neutral amino acid transporter‏ ‎‡9  1‏
919 ‎‡a  transductionofcelllinesbyretroviralvectors‏ ‎‡A  Transduction of Cell Lines by Retroviral Vectors‏ ‎‡9  1‏
919 ‎‡a  transductionofprimaryhematopoieticcellsbyretroviralvectors‏ ‎‡A  Transduction of Primary Hematopoietic Cells by Retroviral Vectors‏ ‎‡9  1‏
919 ‎‡a  transformationandscatteringactivitiesofthereceptortyrosinekinaseronstkinrodentfibroblastsandlackofregulationbythejaagsiektesheepretrovirusreceptorhyal2‏ ‎‡A  Transformation and scattering activities of the receptor tyrosine kinase RON/Stk in rodent fibroblasts and lack of regulation by the jaagsiekte sheep retrovirus receptor, Hyal2‏ ‎‡9  1‏
919 ‎‡a  transformationofmadindarbycaninekidneyepithelialcellsbysheepretrovirusenvelopeproteins‏ ‎‡A  Transformation of madin-darby canine kidney epithelial cells by sheep retrovirus envelope proteins.‏ ‎‡9  1‏
919 ‎‡a  useofdifferentbutoverlappingdeterminantsinaretrovirusreceptoraccountsfornonreciprocalinterferencebetweenxenotropicandpolytropicmurineleukemiaviruses‏ ‎‡A  Use of different but overlapping determinants in a retrovirus receptor accounts for non-reciprocal interference between xenotropic and polytropic murine leukemia viruses.‏ ‎‡9  1‏
919 ‎‡a  useofretroviralvectorsforgenetransferandexpression‏ ‎‡A  Use of Retroviral Vectors for Gene Transfer and Expression‏ ‎‡9  1‏
919 ‎‡a  viralandcellularfosproteinsacomparativeanalysis‏ ‎‡A  Viral and cellular fos proteins: A comparative analysis‏ ‎‡9  1‏
919 ‎‡a  xpr1isanatypicalgproteincoupledreceptorthatmediatesxenotropicandpolytropicmurineretrovirusneurotoxicity‏ ‎‡A  Xpr1 is an atypical G-protein-coupled receptor that mediates xenotropic and polytropic murine retrovirus neurotoxicity‏ ‎‡9  1‏
947 ‎‡a  US‏ ‎‡9  1‏
996 ‎‡2  RERO|A009313924‏
996 ‎‡2  ISNI|0000000436787335‏
996 ‎‡2  SUDOC|19461929X‏
996 ‎‡2  LC|no 93032708‏
996 ‎‡2  DNB|141451785‏
996 ‎‡2  NUKAT|n 99042842‏
996 ‎‡2  LC|n 78062840‏
996 ‎‡2  SUDOC|255881266‏
996 ‎‡2  DNB|117042439‏
996 ‎‡2  LIH|LNB:PA,;=_v_N‏
996 ‎‡2  NUKAT|n 99067508‏
996 ‎‡2  NII|DA0930848X‏
996 ‎‡2  NTA|313087059‏
996 ‎‡2  LC|n 2008027606‏
996 ‎‡2  J9U|987007338152305171‏
996 ‎‡2  RERO|A010117496‏
996 ‎‡2  LC|no2010123787‏
996 ‎‡2  BLBNB|000598288‏
996 ‎‡2  ISNI|0000000483234506‏
996 ‎‡2  ISNI|0000000400578478‏
996 ‎‡2  ISNI|0000000507250827‏
996 ‎‡2  LC|no2015105562‏
996 ‎‡2  PLWABN|9810552585205606‏
996 ‎‡2  KRNLK|KAC200205933‏
996 ‎‡2  NUKAT|n 2012219679‏
996 ‎‡2  CAOONL|ncf11026387‏
996 ‎‡2  NTA|080093817‏
996 ‎‡2  NUKAT|n 2004022894‏
996 ‎‡2  SUDOC|058934537‏
996 ‎‡2  LC|no2006109558‏
996 ‎‡2  LC|n 2001026711‏
996 ‎‡2  PTBNP|1469319‏
996 ‎‡2  SUDOC|159751098‏
996 ‎‡2  ISNI|0000000107515670‏
996 ‎‡2  ISNI|0000000076306402‏
996 ‎‡2  DNB|13982197X‏
996 ‎‡2  DNB|1057627747‏
996 ‎‡2  LC|n 2018000725‏
996 ‎‡2  NII|DA00670047‏
996 ‎‡2  ISNI|0000000057424956‏
996 ‎‡2  BNF|14419184‏
996 ‎‡2  BIBSYS|90320359‏
996 ‎‡2  NTA|315786663‏
996 ‎‡2  NUKAT|n 2002071624‏
996 ‎‡2  SIMACOB|62240611‏
996 ‎‡2  ISNI|0000000108173916‏
996 ‎‡2  RERO|A003595562‏
996 ‎‡2  BNF|12353361‏
996 ‎‡2  LC|n 2014001079‏
996 ‎‡2  RERO|A003595566‏
996 ‎‡2  RERO|A003595567‏
996 ‎‡2  ISNI|0000000067175287‏
996 ‎‡2  LC|n 92072982‏
996 ‎‡2  DNB|1311765573‏
996 ‎‡2  LC|n 85253486‏
996 ‎‡2  RERO|A003595568‏
996 ‎‡2  BNF|12504268‏
996 ‎‡2  RERO|A022937662‏
996 ‎‡2  ISNI|0000000025612629‏
996 ‎‡2  BNF|12904722‏
996 ‎‡2  LC|no2020043714‏
996 ‎‡2  LC|no2017144668‏
996 ‎‡2  JPG|500000349‏
996 ‎‡2  LC|n 2007164872‏
996 ‎‡2  DNB|1147167362‏
996 ‎‡2  LC|n 2018181831‏
996 ‎‡2  DE633|pe30010621‏
996 ‎‡2  NLA|000035702356‏
996 ‎‡2  LC|n 2014006221‏
996 ‎‡2  DNB|132575031X‏
996 ‎‡2  LC|no2008136219‏
996 ‎‡2  NLA|000035905144‏
996 ‎‡2  BNF|17804886‏
996 ‎‡2  NUKAT|n 2015201014‏
996 ‎‡2  NDL|00524455‏
996 ‎‡2  NDL|00524454‏
996 ‎‡2  DNB|126061181‏
996 ‎‡2  BNF|16137934‏
996 ‎‡2  NUKAT|n 02001664‏
996 ‎‡2  ISNI|0000000458797729‏
996 ‎‡2  ERRR|12082934‏
996 ‎‡2  LC|n 94007977‏
996 ‎‡2  ISNI|0000000036199737‏
996 ‎‡2  DNB|1147185107‏
996 ‎‡2  ISNI|0000000023367455‏
996 ‎‡2  ISNI|000000008244465X‏
996 ‎‡2  ICCU|MODV254416‏
996 ‎‡2  ISNI|0000000449603945‏
996 ‎‡2  SUDOC|11130198X‏
996 ‎‡2  NTA|442216742‏
996 ‎‡2  ISNI|000000011455319X‏
996 ‎‡2  DNB|1196380686‏
996 ‎‡2  ISNI|0000000118862571‏
996 ‎‡2  CAOONL|ncf10182877‏
996 ‎‡2  SUDOC|158194268‏
996 ‎‡2  DNB|1183333315‏
996 ‎‡2  LC|no2001031978‏
996 ‎‡2  LC|nb2012020702‏
996 ‎‡2  ISNI|0000000477054680‏
996 ‎‡2  LC|n 86042037‏
996 ‎‡2  NII|DA07157215‏
996 ‎‡2  LC|n 88616221‏
996 ‎‡2  DNB|117042609‏
996 ‎‡2  LC|n 85029339‏
996 ‎‡2  ISNI|0000000053890650‏
996 ‎‡2  LC|no2009050880‏
996 ‎‡2  ISNI|0000000042027229‏
996 ‎‡2  NTA|146889460‏
996 ‎‡2  LIH|LNB:V-58222;=BF‏
996 ‎‡2  LC|n 88204041‏
996 ‎‡2  NUKAT|n 2003071875‏
996 ‎‡2  LC|n 99802324‏
996 ‎‡2  BIBSYS|8068795‏
996 ‎‡2  DNB|188455973‏
996 ‎‡2  LNB|LNC10-000133359‏
996 ‎‡2  CAOONL|ncf10112520‏
996 ‎‡2  LC|n 2002042182‏
996 ‎‡2  DBC|87097969607357‏
996 ‎‡2  ISNI|0000000374812661‏
996 ‎‡2  ISNI|0000000367983622‏
996 ‎‡2  ISNI|0000000107308487‏
996 ‎‡2  LC|nb2020004668‏
996 ‎‡2  ISNI|0000000035574005‏
996 ‎‡2  NTA|336550928‏
996 ‎‡2  DNB|1146606680‏
996 ‎‡2  CAOONL|ncf11962126‏
996 ‎‡2  ISNI|0000000065725054‏
996 ‎‡2  NTA|070301808‏
996 ‎‡2  ISNI|0000000114511379‏
996 ‎‡2  JPG|500488635‏
996 ‎‡2  J9U|987007272478505171‏
996 ‎‡2  BNF|15622229‏
996 ‎‡2  ISNI|0000000110813492‏
996 ‎‡2  NTA|155403648‏
996 ‎‡2  BLBNB|000422059‏
996 ‎‡2  J9U|987007265310205171‏
996 ‎‡2  LC|no2005017669‏
996 ‎‡2  RERO|A009181148‏
996 ‎‡2  LC|no2015019548‏
996 ‎‡2  ISNI|0000000072915489‏
996 ‎‡2  ISNI|0000000031988382‏
996 ‎‡2  BIBSYS|90066256‏
996 ‎‡2  NTA|071291172‏
996 ‎‡2  LC|n 2001010686‏
996 ‎‡2  BNC|981058614499506706‏
996 ‎‡2  LC|no2008033318‏
996 ‎‡2  N6I|vtls000899686‏
996 ‎‡2  NII|DA10400060‏
996 ‎‡2  ISNI|0000000108615374‏
996 ‎‡2  LC|no2012128390‏
996 ‎‡2  BIBSYS|15033415‏
996 ‎‡2  NII|DA17326498‏
996 ‎‡2  ISNI|0000000026970620‏
996 ‎‡2  ISNI|0000000066649911‏
996 ‎‡2  NDL|00450039‏
996 ‎‡2  NDL|00450038‏
996 ‎‡2  ISNI|000000002639108X‏
996 ‎‡2  J9U|987007270795905171‏
996 ‎‡2  LC|n 90607487‏
996 ‎‡2  DNB|115807588X‏
996 ‎‡2  LC|n 2013062697‏
996 ‎‡2  ISNI|0000000081639287‏
996 ‎‡2  NUKAT|n 2010075342‏
996 ‎‡2  BIBSYS|90197101‏
996 ‎‡2  ISNI|0000000034116969‏
996 ‎‡2  NSK|000060948‏
996 ‎‡2  NKC|mub20221137171‏
996 ‎‡2  LC|n 81146632‏
996 ‎‡2  DNB|1181384508‏
996 ‎‡2  NII|DA02279929‏
996 ‎‡2  DNB|1171726708‏
996 ‎‡2  LNB|LNC10-000043734‏
996 ‎‡2  LNB|LNC10-000043735‏
996 ‎‡2  ISNI|0000000080846540‏
996 ‎‡2  RERO|A013769369‏
996 ‎‡2  ISNI|000000005544892X‏
996 ‎‡2  LC|n 85262690‏
996 ‎‡2  ISNI|0000000075506234‏
996 ‎‡2  PLWABN|9810592746705606‏
996 ‎‡2  BIBSYS|90633496‏
996 ‎‡2  ISNI|0000000420235536‏
996 ‎‡2  DBC|87097968703476‏
996 ‎‡2  SUDOC|151227381‏
996 ‎‡2  LC|no2018112052‏
996 ‎‡2  PLWABN|9810693982005606‏
996 ‎‡2  NUKAT|n 2004037159‏
996 ‎‡2  ISNI|0000000116660861‏
996 ‎‡2  LC|n 94800707‏
996 ‎‡2  CAOONL|ncf10895736‏
996 ‎‡2  NKC|js2015860309‏
996 ‎‡2  LC|no2011095290‏
996 ‎‡2  ISNI|0000000488988729‏
996 ‎‡2  ISNI|0000000060824846‏
996 ‎‡2  NII|DA13184766‏
996 ‎‡2  BIBSYS|90170797‏
996 ‎‡2  ISNI|0000000374675652‏
996 ‎‡2  NII|DA05051053‏
996 ‎‡2  ISNI|0000000028397143‏
996 ‎‡2  LC|no2022143010‏
996 ‎‡2  SUDOC|146515277‏
996 ‎‡2  DNB|1163029246‏
996 ‎‡2  NKC|vse2012720191‏
996 ‎‡2  DNB|1053727348‏
996 ‎‡2  LC|n 84800728‏
996 ‎‡2  BNF|15034330‏
996 ‎‡2  DNB|1225061849‏
996 ‎‡2  ISNI|0000000031584089‏
996 ‎‡2  NUKAT|n 2011215211‏
996 ‎‡2  DNB|108938422X‏
996 ‎‡2  BIBSYS|90246896‏
996 ‎‡2  NTA|166245216‏
996 ‎‡2  LC|nb2015000218‏
996 ‎‡2  SUDOC|255319673‏
996 ‎‡2  SUDOC|172656370‏
996 ‎‡2  LC|no2009201464‏
996 ‎‡2  ISNI|0000000119913545‏
996 ‎‡2  ISNI|0000000040704716‏
996 ‎‡2  LC|n 88249411‏
996 ‎‡2  SUDOC|177556099‏
996 ‎‡2  J9U|987007325633005171‏
996 ‎‡2  NUKAT|n 95002992‏
996 ‎‡2  ISNI|0000000389307721‏
996 ‎‡2  LC|no2009084268‏
996 ‎‡2  JPG|500050393‏
996 ‎‡2  ISNI|0000000110444906‏
996 ‎‡2  DNB|1020509147‏
996 ‎‡2  BNE|XX1529449‏
996 ‎‡2  NUKAT|n 2023098872‏
996 ‎‡2  LC|no2017141285‏
996 ‎‡2  PLWABN|9810565628405606‏
996 ‎‡2  SUDOC|225713217‏
996 ‎‡2  NSK|000424135‏
996 ‎‡2  J9U|987007265309705171‏
996 ‎‡2  BIBSYS|90398451‏
996 ‎‡2  BNF|12348359‏
996 ‎‡2  DNB|1227406959‏
996 ‎‡2  BIBSYS|6063922‏
996 ‎‡2  DNB|138103607‏
996 ‎‡2  LC|n 81100228‏
996 ‎‡2  J9U|987007340119005171‏
996 ‎‡2  DNB|1249246016‏
996 ‎‡2  DNB|143883186‏
996 ‎‡2  NTA|108142701‏
996 ‎‡2  LC|n 86838372‏
996 ‎‡2  DNB|1148324879‏
996 ‎‡2  SKMASNL|vtls013103835‏
996 ‎‡2  LC|n 2017059531‏
996 ‎‡2  CAOONL|ncf11278158‏
996 ‎‡2  LC|no2016039979‏
996 ‎‡2  ISNI|0000000053080404‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏